(Q41153683)

27 September 2017

title

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

6 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

6 December 2022

1 reference

H. S. Singer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838678

6 December 2022

I. H. Hahn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838678

6 December 2022

T. H. Moran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838678

6 December 2022

language of work or name

1 reference

1 October 1991

1 reference

full work available at URL

27 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300408

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300408

6 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

6 December 2022

1 reference

27 September 2017

volume

30

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

558-562

1 reference

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

Gilles de la Tourette syndrome after long-term chlorpromazine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

The relationship between stimulant medication and tics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300408

Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment.

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Biogenic amine metabolism in tourette syndrome

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Dopaminergic dysfunction in tourette syndrome

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue.

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Two binding sites for 3H-spiroperidol on rat striatal membranes

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Protein measurement with the Folin phenol reagent

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Rapid and simple method for measuring biogenic amines and metabolites in brain homogenates by HPLC-electrochemical detection

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

[3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Striatal dopamine innervation and receptor density: regional effects of the weaver mutation

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia

6 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

British Journal of Pharmacology

6 December 2022

28

95

765p

Czudek

1988

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Desipramine binding: relationship to central and sympathetic noradrenergic activity

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

[3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease

6 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/ANA.410300408

6 December 2022

Identifiers

1 reference

27 September 2017

1 reference